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Purpose: Human cornea substitutes generated by tissue engineering currently require
limbal stem cells for the generation of orthotypical epithelial cell cultures. We recently
reported that bioengineered corneas can be fabricated in vitro from a heterotypical
source obtained from Wharton’s jelly in the human umbilical cord (HWJSC).
Methods: Here, we generated a partial thickness cornea model based on plastic
compression nanostructured fibrin-agarose biomaterials with cornea epithelial cells on
top, as an orthotypical model (HOC), or with HWJSC, as a heterotypical model (HHC),
and determined their potential in vivo usefulness by implantation in an animal model.
Results: No major side effects were seen 3 and 12 months after implantation of either
bioengineered partial cornea model in rabbit corneas. Clinical results determined by slit
lamp and optical coherence tomography were positive after 12 months. Histological and
immunohistochemical findings demonstrated that in vitro HOC and HHC had moderate
levels of stromal and epithelial cell marker expression, whereas in vivo grafted corneas
were more similar to control corneas.
Conclusion: These results suggest that both models are potentially useful to treat
diseases requiring anterior cornea replacement, and that HHC may be an efficient
alternative to the use of HOC which circumvents the need to generate cornea epithelial
cell cultures.
Keywords: tissue engineering, bioengineered cornea, Wharton’s jelly stem cells, heterotypical human cornea,
artificial cornea
INTRODUCTION
Transplantation of a functional tissue-engineered cornea could contribute to the clinical treatment
of patients with severe corneal defects (Garzon et al., 2014b; Gonzalez-Andrades et al., 2017).
Several approaches have been described for the treatment of diseased corneas from a regenerative
medicine standpoint (Oie and Nishida, 2016). On the one hand, tissue-engineered cell sheets or
individual corneal layers can be efficiently generated in the laboratory using corneal epithelial
cells (Sangwan and Sharp, 2017; Pellegrini et al., 2018; Le-Bel et al., 2019), stromal keratocytes
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(Isaacson et al., 2018) or extra-corneal cells (Nishida et al.,
2004) combined with different types of biomaterials or substrates.
On the other hand, promising models of bioartificial corneas
have been developed by tissue engineering (Ghezzi et al., 2015),
including full-thickness corneas (Griffith et al., 1999; Alaminos
et al., 2006) and anterior lamellar partial thickness corneas
consisting of an epithelial layer with cornea epithelial cells and
a subjacent stromal layer with biomaterials and keratocytes
(Gonzalez-Andrades et al., 2009; Mi et al., 2010; Zaniolo et al.,
2013; Couture et al., 2016; Rico-Sanchez et al., 2019).
However, the clinical translation potential of most of these
strategies is still uncertain and highly dependent on the
availability of adequate limbal stem cell sources for the generation
of bioengineered cornea models with corneal cells. In this regard,
human limbal stem cell cultures raised from limbal biopsies
are difficult to obtain, and the procedure is subjected to the
risk of causing limbal stem-cell deficiency in the healthy eye
(Nishida et al., 2004).
In addition, patients suffering from bilateral limbal stem cell
deficiency (LSD) may not be candidates for limbal biopsy and
need alternative sources of corneal epithelial cells (Nguyen et al.,
2017). For these reasons, the search for alternative cell sources
to generate heterotypical bioartificial human corneas using extra-
corneal cells is a current challenge in tissue engineering.
Previous reports have demonstrated that human
mesenchymal stem cells (MSC) may have the potential to
differentiate into cornea epithelial cells for the generation of
partial human corneas in vitro (Liu et al., 2008; Gomes et al.,
2010; Lin et al., 2013). Among the different types of MSC
that could be potentially used in cornea tissue engineering,
human umbilical cord Wharton’s jelly stem cells (HWJSC)
have several advantages, including accessibility, proliferation
and differentiation potential, and immune-privileged status
(Garzon et al., 2020). In fact, our research group was able to
generate in vitro a biomimetic substitute of the human anterior
cornea using HWJSC as an alternative cell source (Garzon et al.,
2014b). Although promising results were obtained in vitro,
the in vivo usefulness of these bioengineered corneas remains
to be determined.
In the present study, we generated partial human orthotypical
cornea (HOC) models with corneal cells, and human
heterotypical cornea (HHC) models with HWJSC. We then
characterized the main stromal and epithelial markers of these
bioengineered cornea substitutes both in vitro and in vivo to
determine the differentiation potential of HWJSC and the clinical
translational potential of bioengineered corneal substitutes with
this source of stem cells.
MATERIALS AND METHODS
Cell Isolation and Culture
To generate primary cultures of human cornea stromal and
epithelial cells, we used limbal sclero-cornea rings that were
discarded after cornea transplant surgery. First, cornea remnants
attached to the limbus were isolated by surgical dissection
and digested in Clostridium histolyticum type-I collagenase
(Thermo Fisher Scientific, Waltham, MA, United States) for 6 h
at 37◦C. Isolated keratocytes were obtained by centrifugation
and cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum, 4 mM L-glutamine and
1% antibiotic–antimycotic solution (Thermo Fisher Scientific).
Then the limbal tissue was carefully dissected and small explants
were cultured directly in Petri dishes with epithelial cell culture
medium (Garzon et al., 2014b). HWJSC were isolated from five
human umbilical cords obtained from cesarean deliveries using
published protocols (Garzon et al., 2014a). First, arteries and
veins were removed from the umbilical cord, and the Wharton’s
Jelly tissue was surgically dissected and digested with a mixture
of type-I collagenase (Thermo Fisher Scientific) and a 0.5 g/L
trypsin – 0.2 g/L EDTA solution (Sigma-Aldrich, St. Louis,
MO, United States). Cells were harvested by centrifugation and
cultured in 75 cm2 culture flasks using AmniomaxTM culture
medium (Thermo Fisher Scientific). All cell cultures were kept
in a cell incubator at 37◦C with 5% CO2 using standard cell
culture conditions.
All methods and experimental protocols were performed in
accordance with relevant guidelines and regulations according
to the Association for Research in Vision and Ophthalmology
(ARVO) Statement for the Use of Animals in Ophthalmic and
Vision Research. For the use of human tissues, the project was
approved by the local Human Research and Ethics Committee of
the province of Granada -PEIBA- (numbers 9/2017 and 3/2016),
and all tissue donors or their parents and/or legal guardians
provided their informed consent.
Generation of HOC and HHC Cornea
Models
Orthotypical models of the human cornea containing cornea cells
(HOC) and heterotypical models containing non-corneal cells
as the epithelial cell source (HHC) were generated with fibrin-
agarose biomaterials with a final agarose concentration of 0.1% as
previously reported by our research group (Gonzalez-Andrades
et al., 2009; Garzon et al., 2014b). To do so, we first fabricated
a biomaterial containing corneal stromal cells that will act as a
biological substitute of the corneal stroma, and we then generated
an epithelial layer (with corneal or extra-corneal cells) on top of
this stroma substitute (Alaminos et al., 2006; Gonzalez-Andrades
et al., 2009; Ionescu et al., 2015) to resemble the structure of
the human native cornea. To generate the stromal substitute, we
used the following protocol: per each ml of mixture, 760 µl of
human plasma (obtained from healthy blood donors) were mixed
with 15 µl of tranexamic acid (Amchafibrin, Fides-Ecofarma,
Valencia, Spain), 75 µl of DMEM (Thermo Fisher Scientific)
containing 100,000 cultured stromal cells (activated fibroblasts),
50 µl of melted 2% type-VII agarose in PBS (both, from
Sigma-Aldrich) and 100 µl of 1% CaCl2 (Sigma-Aldrich). This
mixture was rapidly aliquoted in Transwell cell culture inserts
with 0.4 µm porous membranes (Corning-Costar, Corning, NY,
United States) and allowed to jellify at 37◦C for at least 6 h. Then,
HOC models were generated by subculturing the previously
cultured cornea epithelial cells on top of the stroma substitutes,
whilst HHC models were generated with HWJSC instead of
epithelial cells. In both models, stratification and differentiation
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of the epithelial-like cell layer were promoted with an air–liquid
culture technique. This technique was performed by lowering the
amount of culture medium in the porous inserts, so that only the
stromal substitute remained submerged, whereas the developing
epithelium was in direct contact with air and received nutrition
from the stromal layer (Reichl and Muller-Goymann, 2003).
Finally, bioengineered corneas were subjected to plastic
compression nanostructuration (Ionescu et al., 2011). This
technique was previously used to induce the formation of
irreversible covalent interactions and hydrogen bonding between
the molecules of the biomaterial, resulting in a significant
improvement of the biomechanical properties of these artificial
tissues that allowed surgical handling (Ionescu et al., 2011;
Campos et al., 2016). For this, bioengineered corneas were
placed between a pair of sterile nylon filter membranes (Merck-
Millipore, Darmstadt, Germany), and two pieces of Whatman
3 mm absorbent paper (Sigma-Aldrich) were set in contact
with each filter membrane. Then, a flat glass surface weighing
500 g was used to apply a homogeneous pressure on the surface
of the system for 3 min. Finally, human bioartificial corneas
were carefully retired and kept in PBS to prevent them from
excessive dehydration.
In vivo Evaluation of HOC and HHC
Cornea Models in Laboratory Animals
Animal study design: in order to characterize both cornea
models in vivo, samples were implanted on the anterior cornea
surface of New Zealand laboratory rabbits using the DALK
technique. A total of 20 rabbits were included in the study,
which were randomly assigned to one of the following groups:
(1) four animals were grafted with HOC and euthanatized after
3 months of follow-up, (2) four animals with HOC analyzed after
12 months, (3) four animals with HHC analyzed after 3 months,
(4) four animals with HHC analyzed after 12 months, and (5) four
non-operated rabbits used as controls.
Animals were deeply anesthetized by an intramuscular
injection of xylazine (5 mg/kg) followed 10 min later by an
intramuscular injection of ketamine (25 mg/kg), and local
anesthetics drops were administered in the eye. Then the
right eye was exposed, and the anterior layers of the cornea
(approximately, two thirds of the stromal thickness) were
surgically removed using a surgical microscope. To do that, a
manual keratotome was first used to make a circular incision
approximately 6 mm in diameter and 200 µm deep in the corneal
thickness. Then an air bubble was injected into the central layer
of the cornea stroma with a Hessburg-Barron vacuum trephine,
and an ophthalmic crescent knife was used to horizontally dissect
the most external stromal layers along with the superjacent
epithelium. The limbus was preserved in all eyes. After careful
debridement of the cornea surface, the bioengineered HOC or
HHC was placed on this surface and sutured to the remaining
cornea with 10/0 nylon suture stitches. Local antibiotics and
anesthetics drops were administered after surgery. To protect the
artificial tissue from mechanical damage, the eyelid of the treated
eye was closed for 1 week. In all animals, the left eye was not
treated and served as a control.
Ophthalmic evaluation was carried out every week, and
slit-lamp bio-microscopy and anterior segment optical
coherence tomography (OCT) was performed at the moment
of the euthanasia of each animal (3 and 12 months of the
surgical procedure). Both eyes were examined in each
animal, and major side effects were registered, including
tumorigenesis, hemorrhage, rejection or infection. The presence
of inflammation was identified by the presence of hyperemia or
neovascularization. Then, all eyes were surgically extracted and
analyzed histologically as described below.
Animal experimentation was approved by the regional ethical
committee (Ethics and Animal Experimentation Committee of
the Andalusian Directorate of Agricultural Production – CEEA),
ref. number 25/06/2018/099.
Histological and Immunohistochemical
Evaluation of HOC and HHC Cornea
Models
Histological methods were used to evaluate in vitro HOC and
HHC samples corresponding to 1, 2, and 3 weeks of development
and in vivo HOC and HHC samples grafted in laboratory animals
for 3 and 12 months. Samples were fixed in 3.7–4.0% wt/vol
buffered formaldehyde for 24 h at 4◦C and dehydrated in ethanol
series (1 h in 70% ethanol, two incubations of 1 h in 96% ethanol,
two incubations of 1 h in 100% ethanol), cleared in xylene (two
incubations of 1 h) and embedded in paraffin (two incubations
of 1 h in paraffin melted at 60◦C) using an automated Citadel
Tissue Processor (Thermo Fisher Scientific). Tissue sections 5 µm
thick were obtained and placed on glass slides, dried at room
temperature, dewaxed with three incubations of 5 min in xylene
and rehydrated with an ethanol series (three incubations of 5 min
in 100%, two incubations of 5 min in 96%, 5 min in 70%, 5 min
in 50% ethanol, and 5 min in distilled water).
For histological analysis, tissue sections were incubated for
3 min in hematoxylin (PanReac AppliChem, Barcelona, Spain),
rinsed in tap water for 5 min, stained with eosin (PanReac
AppliChem) for 1 min and dehydrated using an ethanol series (3
incubations of 5 min in 96% and 3 incubations of 5 min in 100%
ethanol), xylene (3 incubations of 15 min) and cover-slipped
using Permount (Fisher Scientific International, Pittsburgh, PA,
United States). Tissue sections stained with H&E were used to
quantify the number of cell layers in the corneal epithelium.
In each sample, the epithelial layer was examined using 600×
magnification, and the number of cell layers was determined by
three expert histologists.
Immunofluorescence assays in tissue sections were performed
using previous standardized protocols (Martin-Piedra et al.,
2017). Samples were first treated for 25 min with 0.01 M
citrate buffer (Dako, Glostrup, Denmark) at 95◦C for antigen
retrieval. After rising in PBS, samples were preincubated in
prehybridization buffer containing 10% donkey serum, and
primary antibodies were applied and incubated for 2 h at
room temperature. Then, samples were washed three times in
PBS and secondary FITC-conjugated anti-mouse or Cy3-anti-
rabbit secondary antibodies (Sigma-Aldrich) were used at 1:500
dilution. Tissues were then counterstained using DAPI mounting
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medium (Vector Laboratories, Burlingame, CA, United States)
and cover-slipped. Analysis was performed using a Nikon
Eclipse 90i fluorescence microscope. Primary antibodies used
for immunofluorescence analysis were specific of the cornea
epithelium: anti-cytokeratin 3/12 (Abcam ab68260), plakoglobin
(Abcam ab12083), crystallins CRY-αA (Santa Cruz sc-28306),
CRY-αB (Millipore ABN185), CRY-β (Santa Cruz sc-22745),
CRY-λ1 (Sigma Prestige HPA040403), and CRY-Z (Abcam
ab154842). As the manufacturers claims that anti-PKG and
anti-CRY-λ1 antibodies are specific for human antigens, these
were therefore used to specifically identify human cells. The
immunofluorescence results were analyzed semiquantitatively by
three independent histologists in a blinded manner to reduce
potential biases. Each histologist scored the positive signal in each
sample as strong (+++), moderate (++), slight (+), very slight
(±) or negative (−), as previously described (Garzon et al., 2009).
For immunohistochemistry, tissue sections were treated with
3% H2O2 to quench endogenous peroxidase, and antigen
retrieval and prehybridization were carried out as described for
immunofluorescence. Then, samples were incubated overnight
at 4◦C in anti-type I collagen (Acris R1038) or anti-vimentin
(Sigma V6630) primary antibodies and washed in PBS. Then,
peroxidase-labeled secondary antibodies (Vector Laboratories)
were used and the signal was detected using a diaminobenzidine
(DAB) development kit (Vector Laboratories). In both cases
(immunofluorescence and immunohistochemistry), isotype-
specific immunoglobulins were used instead of the primary
antibodies as negative controls.
For scanning electron microscopy (SEM), samples were
fixed in cacodylate-buffered 2.5% glutaraldehyde, dehydrated in
alcohol series (50, 70, 96, and 100% ethanol, 30 min in each
concentration) and dried by the critical point method using a
Critical Point Dryer (Bal-Tec, Los Angeles, CA, United States).
This method consists in replacing all the ethanol embedding the
tissue by liquid carbon dioxide at high pressure, which is then
evaporated at low pressure, resulting in a critically dried sample.
Then, tissues were sputter-coated with gold-palladium using a
Mini Sputter Coater System (Quorum Technologies Ltd., Lewes,
United Kingdom) and examined a Quanta 200 scanning electron
microscope (FEI, Eindhoven, Netherlands).
For transmission electron microscopy (TEM), samples were
fixed in cacodylate-buffered 2.5% glutaraldehyde for 8 h, washed
three times in cacodylate duffer and postfixed in 1% osmium
tetroxide for 90 min. After fixation, samples were dehydrated
in increasing concentrations of acetone (30, 50, 70, 95, and
100%), embedded in Spurr’s resin and cut into ultrathin sections
with an ultramicrotome. For analysis, sections were stained with
aqueous uranyl acetate and lead citrate and examined with an
EM902 transmission electron microscope (Carl Zeiss Meditec,
Inc., Oberkochen, Germany).
Optical Properties of the HOC and HHC
Cornea Models
In order to characterize the different cornea models from
an optical standpoint, we analyzed the transmittance of each
sample and the reduced scattering and absorption coefficients.
The inverse adding-doubling method was used to determine
scattering and absorption using total reflection and total
transmission measurements made with a single integrating
sphere, as previously described (Ionescu et al., 2015, 2017).
Total diffuse reflection and transmission measurements were
made with a 158.2-mm-diameter integrating sphere (Oriel,
model 70674. Newport Corp., Irvine, CA, United States) with
a 11-mm-diameter detector port and a 4-mm-diameter sample
port with a baffle between ports. The entrance port was
15 mm in diameter. All measurements were obtained for
HOC and HHC corneas and native control corneas at 457.9,
488, and 514.5 nm with an argon ion laser (Stellar-Pro-L
Model, Modu-Laser, Centerville, UT, United States) and at
632.8 nm with a He-Ne laser (30564 Model, Research Electro-
Optics, Boulder, CO, United States). The maximum output
power was 1000 mW ± 5% for the argon laser and 12 mW
for the He-Ne laser. The diameter of both argon and He-
Ne lasers beams was 2 mm. Three reflection measurements
were made in each sample, and were referenced to a 98%
Optopolymer reflectance standard (OPST3-C, Optopolymer,
Munich, Germany) and a dark measurement (with the sample
port empty). For transmission, three measurements were made in
each corneal model and a control cornea, and were referenced to
100% with the lasers illuminating the open port (empty port) and
a dark measurement with an open port but with no illumination
from the lasers. Reflectance of the sphere wall, thickness, and
refractive index of the cornea models and the control native
cornea were also measured and used to calculate the absorption
and reduced scattering coefficients, using the inverse adding-
doubling method (Prahl et al., 1993; Sardar et al., 2005, 2009;
Yust et al., 2012).
Statistical Analysis
Quantitative results obtained for the optical parameters
(transmittance, absorption and reduced scattering) were
analyzed statistically to identify differences among samples.
First, a global comparison of all study samples (HOC, HHC, and
controls) was carried out using the Kruskal–Wallis test. Then,
post hoc comparisons between two specific types of corneas
(HOC vs. controls, HHC vs. Controls, and HOC vs. HHC)
was performed using the Mann–Whitney test. Non-parametric
tests were used because the parameters analyzed here did not
fulfill the criteria for parametric testing. A Bonferroni-adjusted
P-value of 0.001 was considered as statistically significant for
the double-tailed tests, since numerous statistical comparisons
were carried out at the same time. P-values between 0.05 and
0.001 were considered as marginally significant, meaning that
these values would have been considered as significant if the
Bonferroni correction had not been applied.
RESULTS
Clinical Results
In vivo analyses of generated HOC and HHC models allowed us
to evaluate the safety and biointegration of bioartificial corneas.
In this regard, we found no signs of tumorigenesis, hemorrhage,
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rejection, infection, or other major side effects in any of the
animals. Macroscopic examination of the rabbit eyes revealed
that HOC and HHC resulted in corneas with some inflammatory
signs around the suture stitches, especially 3 months after in vivo
implantation. However, inflammation tended to resolve after
12 months. In fact, ophthalmic evaluation of HOC revealed
some inflammation around the stitches in 2 out of the 4 rabbits
analyzed at 3 months, and 1 out of 4 rabbits at 12 months. For
HHC, 2 of the 4 animals showed inflammation at 3 months,
and none at 12 months (Figure 1). Slit lamp analyses showed no
differences between the two types of cornea and the controls, with
a well-defined linear structure of the cornea in all cases. OCT
evaluation revealed a regular structure consisting of a corneal
stroma with a normal overlying epithelium in control eyes.
Cross-sectional images obtained by OCT on corneas undergoing
surgery showed that the grafted tissue was tightly attached to the
host cornea stroma in all cases. However, an interface between
both tissues was clearly identifiable in all HOC and HHC eyes
after 3 and 12 months (Figure 1).
Histological Analysis
Histological evaluation of different samples by H&E are shown
in Figure 2A. Analyses of in vitro HOC samples showed a
stratified epithelium consisting of polygonal and rounded cells.
Quantification of the number of cell layers disclosed that the cell
number tended to increase with time in culture: at 1 week, HOC
had an average of 2 epithelial cell layers, at 2 weeks, we found
an average of 4.5 layers, and an average of 6 layers were found at
week 3. Analysis of in vitro HHC samples showed that these cells
tended to be more flattened as compared to HOC, and showed
an average of 1.5 cell layers at week 1, 6.5 layers at week 2, and 9
layers at week 3. Regarding the stromal cells, we found that these
cells were scattered throughout the fibrin-agarose biomaterial in
all sample types.
In vivo grafting resulted in higher levels of tissue
differentiation in both types of cornea. In all in vivo samples,
the epithelium consisted of an average of 6.5 epithelial cell
layers showing a well-organized stratification pattern very
similar to control corneas. Moreover, the stroma was formed
by a dense, highly organized fibrillar mesh containing large
numbers of stromal cells after 12 months of development,
whereas the interface between the host tissue and the implant
was detectable only in samples corresponding to 3 months after
in vivo implantation.
Further characterization of the in vivo HOC and HHC
samples with TEM (Figure 2B) confirmed the presence of a
stratified corneal epithelium that showed polarity and signs
of differentiation such as rounded cells in the basal layer
and flattened cells on top, cell–cell cohesion, and a basement
membrane underlying the corneal epithelium. In the stroma,
abundant collagen fibers were found with different spatial
orientation corresponding to different corneal stroma layers, and
some stromal cells were detected between adjacent stromal layers.
Analyses with SEM (Figure 2B) showed that the surface
of HOC and HHC was fully covered by an epithelial layer
consisting of flat polygonal cells exhibiting evident signs of cell
desquamation and cell renewal.
Corneal Stroma Differentiation
Determined by Immunohistochemistry
Analyses of cells in the stroma of different samples showed
that most cells were positive for the vimentin stromal
marker both in vitro and in vivo (Figure 3A). In addition,
collagen I immunohistochemistry (Figure 3B) showed that HOC
FIGURE 1 | Clinical results in HOC and HHC bioartificial corneas grafted on the surface of rabbit eyes after 3 and 12 months of follow-up. Top images show the
macroscopic findings; central images show slit lamp observations; lower images illustrate OCT findings. Controls are non-grafted normal rabbit eyes. HOC, human
orthotypical cornea; HHC, human heterotypical cornea; OCT, optical coherence tomography. Arrows correspond to the inflammatory signs around the suture
stitches.
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FIGURE 2 | Histological evaluation of different samples with hematoxylin and eosin (H&E) staining (A), and electron microscopy (B). HOC, human orthotypical
cornea; HHC, human heterotypical cornea. A, B, E, and F show TEM images of HOC and HHC epithelium at different magnifications. C and G show TEM images of
corneal stroma. D and H show SEM images of the corneal epithelial surface in HOC and HHC. Controls are normal human corneas (CTRh) and normal rabbit
corneas (CTRr). Blue arrows correspond to the interface between the host tissue and the implant, and some illustrative stromal cells are highlighted with arrow
heads. Scale bars: 100 µm for H&E and SEM, and 10 µm for TEM images.
maintained in vitro did not express this marker, but collagen
was present in in vivo samples at 3 months and its expression
was increased at 12 months. In contrast, HHC showed positive
collagen expression after 2 weeks of in vitro development, and
expression increased steadily thereafter. The highest levels of
expression were seen in vivo, especially after 12 months being
similar to control group (Figure 3B).
Corneal Epithelium Differentiation
Determined by Immunofluorescence
To determine the epithelial phenotype of the epithelial layer in
HOC and HHC cornea substitutes, we analyzed CK3/12 and PKG
expression. Orthotypical epithelial cells produced positive signals
for CK3/12 cytokeratin in all stages of in vitro development,
especially in the most superficial layer (Figure 4A and Table 1).
This expression increased and showed strong positivity in vivo
and was seen in all epithelial layers, being comparable to controls.
However, HHC were initially negative and turned moderately
positive after 3 weeks of in vitro development. In our in vivo
samples of HOC and HHC, expression levels were strong and
similar to those in control human corneas.
Analysis of the cell–cell junction protein PKG (Figure 4B and
Table 1), also showed positive expression in all HOC samples,
especially at week 3 in vitro and in all in vivo samples, which
showed strong expression. For the HHC samples, in vitro corneas
were moderately positive for PKG from week 2 of development,
and in vivo samples were strongly positive. Interestingly, PKG
expression was very low in control rabbit corneas and strongly
positive in control human tissues.
Crystallin Expression
Immunohistochemical assays for crystallins, key proteins in
corneal transparency, showed that all proteins were highly
expressed by the control human cornea epithelium, although
control rabbit cornea showed slight or very slight expression
levels of CRY-Z and CRY-λ1 (Figures 5, 6 and Table 1). In
the bioengineered corneas, expression of all crystallins tended
to increase with time in all corneas maintained in vitro,
with highest levels in corneas with the highest number of
epithelial cell layers except for CRY-λ1, which was moderately
positive from week 1 (Figure 6B and Table 1). In general,
the expression levels tended to be higher in in vitro HOC
samples than in in vitro HHC samples, except for CRY-Z
(Figure 6C and Table 1), which was expressed more strongly
in HHC than HOC, and CRY-λ1, which was expressed at
similar levels in both models. After 3 months of in vivo
development, HOC and HHC samples were comparable to
control human corneas for CRY-αA (Figure 5A and Table 1)
and CRY-β (Figure 6A and Table 1), whereas lower expression
was found for the rest of crystallins analyzed in this work.
At 12 months of in vivo development, the levels of CRY-αA
expression in both HOC and HHC were strong and similar
to human control cornea, and this was also the case of CRY-
αB (Figure 5B and Table 1) and CRY-Z for the HHC samples.
Controls in vivo HOC samples at 12 months showed similar
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FIGURE 3 | In vitro and in vivo analyses of corneal stroma differentiation determined by immunohistochemistry for vimentin (VIM, A) and type I collagen (COL1, B).
HOC, human orthotypical cornea; HHC, human heterotypical cornea. Controls are normal human corneas (CTRh) and normal rabbit corneas (CTRr). Scale bars:
100 µm for all images.
FIGURE 4 | Differentiation of corneal epithelium in vitro and in vivo determined by immunohistochemistry for cytokeratin 3/12 (CK3/12, A) and plakoglobin (PKG, B).
HOC, human orthotypical cornea; HHC, human heterotypical cornea. Controls are normal human corneas (CTRh) and normal rabbit corneas (CTRr). Scale bars:
100 µm.
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CK3/12 HOC + + ++ +++ +++ +++ +++
HHC − − ++ +++ +++
PKG HOC + + +++ +++ +++ +++ ±
HHC − ++ ++ +++ +++
CRY-αA HOC + ++ +++ +++ +++ +++ +++
HHC + + +++ +++ +++
CRY-αB HOC − ± + ± ++ +++ +++
HHC ± + + + +++
CRY-β HOC + + ++ ++ ++ ++ ++
HHC − + + ++ +
CRY-λ1 HOC ++ ++ ++ + + +++ ±
HHC ++ ++ ++ + ++
CRY-Z HOC − + ++ ++ ++ +++ +
HHC + ++ +++ ++ +++
HOC, human orthotypical cornea; HHC, human heterotypical cornea.
FIGURE 5 | Differentiation of corneal epithelium in vitro and in vivo determined by immunohistochemistry for crystallins CRY-αA (A) and CRY-αB (B). HOC, human
orthotypical cornea; HHC, human heterotypical cornea. Controls are normal human corneas (CTRh) and normal rabbit corneas (CTRr). Scale bars: 100 µm.
moderate expression. However, in vivo expression levels of
CRY-αB, CRY-λ1, and CRY-Z were lower in HOC samples at
12 months as compared to human controls, and HHC samples
at 12 months showed lower CRY-β and CRY-λ1 expression levels
than human controls.
Optical Behavior
Tests of the optical behavior of controls and HOC and HHC
bioengineered human corneas showed that light transmittance
in all samples depended on the wavelength, and statistically
significant differences were found among the different samples
analyzed here. Globally, average values of bioengineered corneas
represented approximately 60% of the transmittance in control
corneas (approximately 80% for all HOC samples and 30%
for al HHC samples) (Figure 7A). Interestingly, the duration
of development in culture did not significantly influence the
transmittance capacity of in vitro samples (P > 0.05). However,
the type of sample was directly related with this parameter, and
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FIGURE 6 | Differentiation of corneal epithelium in vitro and in vivo determined by immunohistochemistry for crystallins CRY-β (A), CRY-λ1 (B) and CRY-Z (C). HOC,
human orthotypical cornea; HHC, human heterotypical cornea. Controls are normal human corneas (CTRh) and normal rabbit corneas (CTRr). Scale bars: 100 µm.
HOC in vitro samples showed significantly higher transmittance
than HHC in vitro samples (P = 1.57 × 10−272). The absorption
and reduced scattering coefficients values of HOC in vitro
samples were significantly higher than controls (P = 2.31× 10−5
for absorption and P = 1.81× 10−39 for scattering), and the same
behavior was found for HHC in vitro samples (P = 1.78× 10−122
for absorption and P = 2.37 × 10−199 for scattering). However,
HOC showed significantly lower levels of absorption and reduced
scattering than HHC in vitro samples (P = 1.01 × 10−204 for
absorption and P = 3.78× 10−285 for scattering) (Figures 7B,C).
When HOC and HHC were grafted in vivo, we found
a substantial increase in transmittance values. In HOC and
HHC in vivo models 3 months after implantation, global mean
transmittance was approximately 55 and 63%, respectively,
corresponding to approximately 66 and 76%, respectively of
the transmittance in control corneas. Therefore, we found
an increase of transmittance 12 months after implantation,
with transmittance values of approximately 75% for both
HOC and HHC, corresponding to 90% of control corneas.
Differences between HOC and HHC were marginally significant
at this time (P = 0.00719), but both cornea models were
significantly lower than controls (P = 1.82 × 10−180 for HOC
and P = 2.96 × 10−196 for HHC). Regarding the absorption
coefficient, we found that both HOC and HHC had significantly
higher absorption coefficients than controls after 3 months of
follow-up (P < 1.00 × 10−100 for HOC and HHC), with HOC
being higher than HHC (P = 0.00001). However, in vivo samples
12 months after implantation showed absorption coefficients that
were lower than those in control corneas, with differences being
statistically significant (P < 1.00 × 10−100). Finally, we found
that the reduced scattering coefficients of HOC and HHC after
3 months were lower than in vitro samples, although did not
reach the low levels of control corneas (P < 1.00 × 10−100
for HOC and P = 4.84 × 10−302 for HHC). After 12 months,
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FIGURE 7 | Optical properties of cornea models in vitro and in vivo determined with the inverse adding-doubling method. (A) Transmittance of each type of cornea;
(B) absorption coefficient; (C) reduced scattering coefficient. HOC, human orthotypical cornea; HHC, human heterotypical cornea; HC, human artificial corneas
(HOC and HHC). Controls are normal rabbit corneas (CTR). a: differences with controls were statistically significant; b: differences with HC in vivo at 3 m were
statistically significant; c: differences with HOC in vitro were statistically significant; d: differences with HHC in vitro were statistically significant.
reduced scattering values were very similar to control corneas,
although statistical differences with controls were detected
(P = 1.58 × 10−111 for HOC and P = 2.36 × 10−88 for HHC).
At this time, differences between HOC and HHC were marginally
significant (P = 0.19009) for the reduced scattering.
DISCUSSION
The potential usefulness of novel HHC models lies in their ability
to support the in vitro construction of human bioartificial cornea
substitutes without the drawbacks associated with the use of
autologous limbal stem cells (Behaegel et al., 2017). For this
reason, we evaluated the in vitro and in vivo behavior of novel
HHC substitutes generated from HWJSC.
Our results showed that both HHC and HOC cornea
substitutes may hold potential for clinical use, and in vivo
outcomes obtained with both cornea types showed no significant
side effects on the host eyes. The initial inflammatory process
found at 3 months was self-limited, and most cases evaluated
at 12 months were devoid of significant inflammation. This
was especially evident in HHC, which did not show any case
of inflammation after 12 months. Although the differences
with HOC were not substantial at this time (one case vs. no
cases), we might hypothesize that the use of MSC in HHC
could exert a positive influence in terms of inflammation. Even
though future works should be carried out with a larger sample
size to confirm or not this hypothesis, the immunomodulatory
effects of HWJSC have been previously demonstrated in different
settings (El Omar et al., 2014; Garzon et al., 2020). Analyses
with OCT disclosed adequate biointegration of the grafted tissue
with host cornea demonstrated by a close attachment of both
tissue layers, albeit with a detectable limit between the two
structures after 12 months. In this regard, it is well known that
complete integration of tissues implanted in the cornea, including
human keratoplasty, may progress slowly due to the avascular
nature of the human cornea (Amiri et al., 2017). In fact, it has
been demonstrated that a transplanted cornea could be easily
detached by mild trauma or physical activity several years after
the transplantation procedure (Jafarinasab et al., 2012).
In addition, our histological analyses confirmed previous
reports (Garzon et al., 2014b) showing that HWJSC were able
to differentiate in vitro into an epithelial-like layer on top of the
stromal substitutes, although the histological and morphological
patterns of both cornea types showed some differences that
suggest that the differentiation process is not complete in vitro
(Garzon et al., 2014b). However, the epithelial layer in both HOC
and HHC corneas became similar to the native human cornea
epithelium once were grafted in vivo. This finding suggests that
the in vivo environment and the local release of soluble paracrine
factors may be necessary to induce and enhance terminal cell
differentiation of HWJSC (Alfonso-Rodriguez et al., 2015).
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Analyses of the corneal stroma showed that the grafted
bioengineered stroma substitute was integrated into the host
cornea, with no evidence of rejection or other side effects
at the histological level. Our results confirmed that stromal
cells expressed vimentin, which is essential for normal growth,
differentiation, integrity and function in corneal cells as
previously demonstrated (Kivela and Uusitalo, 1998). In
addition, our analyses confirmed the presence of mature collagen
fibers in corneas grafted in vivo, and also in in vitro samples
with the HHC model. The early expression of collagen by
HHC cells may be explained by the high biosynthetic activity
of WHJSC, which derive from a mucous connective tissue that
is committed to produce large amounts of fibrillar and non-
fibrillar extracellular matrix components in the umbilical cord
(Corrao et al., 2013). In summary, the presence of vimentin-
positive stromal cells immersed within a collagen-rich matrix
resembling the native corneal stroma suggests that the implanted
substitute may be undergoing adequate stromal differentiation
after in vivo grafting. Moreover, the in vivo formation of a
basement membrane on top of the stroma may support epithelial
cell development, which appears to be a critical factor in corneal
healing and transparency (Torricelli et al., 2016).
Analysis of the epithelial layer in the bioartificial cornea
models demonstrated that HHC were able to develop a stratified
epithelial-like structure similar to that seen in the HOC model.
Strikingly, both HHC and HOC grafted in vivo showed high
levels of expression of the cornea epithelium markers CK3/12 and
PKG and several crystallins, similar to the levels seen in native
human corneas. However, HHC showed late in vitro expression
of both markers compared to HOC. These findings are not
unexpected, since the HOC model was constructed with corneal
cells that are previously committed to cornea differentiation,
whereas HWJSC would likely require a differentiation induction
process driven by different factors (Garzon et al., 2020). In
addition to CK3/12 and PKG, further analyses should be carried
out to determine the expression of other markers of corneal
epithelial cells and limbal stem cells, such as KRT15, KRT17,
1Np63, and ABCG2 (Ebrahimi et al., 2009; Wright and Connon,
2013). In this regard, we previously demonstrated that HOC show
positive expression of most of these markers by microarray (Rico-
Sanchez et al., 2019), (data are accessible at https://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE86584), and that native
HWJSC express high amounts of MSC undifferentiation markers,
which decrease upon epithelial differentiation coinciding with a
positive expression of specific differentiation markers (Alaminos
et al., 2010). Whether or not this also occurs in our HHC
model remains unexplored, although the positive results found
with H&E, TEM, and SEM analyses support the hypothesis that
HWJSC may have been able to differentiate to corneal epithelium.
An important unsolved question is the adequate
characterization of the xenograft that allow us to definitely
identify the origin of the cells found in the rabbit cornea. Rabbit
limbal epithelial stem cells show rapid self-renewal (Zheng et al.,
2019), and grafted human cells may disappear after several
months of in vivo follow-up. In this regard, we found that two
primary antibodies (anti-PKG and anti-CRY-λ1) showed positive
expression in corneas grafted in rabbits, and very low expression
in rabbit controls. Although this supports the possibility that
the cells found in corneas grafted in vivo were human, survival
of the grafted epithelial cells should be confirmed in future
studies using FISH analysis or other highly sensitive techniques
(Catanese et al., 2011).
Apart from the role of crystallins as corneal epithelium
marker, a crucial aspect in the analysis of bioengineered
human corneas is transparency, which is directly dependent
on many factors such as the presence of cornea crystallins
(Cvekl and Zhang, 2017). Although crystallins are not well
known, it has been demonstrated that their contribution to
cornea transparency is directly related to their molecular weight
and three-dimensional structure, and their spatial structure
can control light scattering (Tardieu, 1998).Transparency is
essentially controlled by α crystallins, which are the biggest
of these proteins and have adequate structure determining
corneal transparency (Tardieu, 1998). Other crystallins with
lower molecular weights such as crystallin β, λ, and Z could
influence corneal transparency to a lesser extent. Analysis
of crystallin expression should be therefore considered in
corneas developed by tissue engineering. In the present study,
we confirmed that bioengineered corneas maintained in vitro
showed low expression of most cornea crystallins compared to
human controls, as previously reported by our group (Garzon
et al., 2014b). The low expression of CRY-αA and CRY-αB
shown by in vitro samples coincided with the lowest levels
of transparency (as determined by light transmittance) and
the highest levels of light absorption and reduced scattering,
especially in the first weeks of development, and suggest that
the corneal epithelium differentiation level of these samples was
low. Remarkably, the expression levels of collagen type I also
tended to be low in corneas maintained in vitro, suggesting
that an appropriate organization of the stromal fibers is crucial
for corneal transparency (Meek and Knupp, 2015). In contrast,
bioengineered HHC and HOC corneas grafted in vivo showed
improved transparency after follow-up for 12 months. This
would be expected to correlate with the higher expression of
crystallin epithelial markers in our in vivo samples. Indeed,
the levels of CRY-αA, CRY-αB, and CRY-Z became similar to
control corneas in HHC, and the levels of CRY-αA and CRY-
β were similar to control corneas in HOC. The transparency
of in vivo corneas determined by light transmittance did not
reach the values in native corneas, but was approximately 90%
of controls after 12 months, with no differences between both
models. Together, these findings suggest that bioengineered
corneas require prolonged in vivo periods to synthesize and
release key proteins related to transparency, such as collagen type
I and several types of crystallins.
One of the limitations of the present study is the need of
analyzing additional limbal stem cell markers in HOC and HHC
by immunohistochemistry, along with the previously mentioned
need of confirming the human nature of the epithelial layer. In
addition, the bioengineered corneas generated in this work are
devoid of the cornea endothelial layer, and future studies should
be focused on the generation of full-thickness bioartificial corneas
including the epithelial, stromal and endothelial corneal layers
(Giasson et al., 2014).
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CONCLUSION
Altogether, our results suggest that bioartificial cornea models
may show adequate in vivo biointegration levels, which
may support their clinical use. HWJSC showed cornea
epithelial differentiation potential and may be considered as
a potential alternative epithelial cell source for the generation
of human corneas by tissue engineering without the need
of using epithelial cell cultures established from human
cornea biopsies.
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